Discovery of drug mode of action and drug repositioning from transcriptional responses
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
A bottleneck in drug discovery is the identification of the molecular targets of a compound (mode of action, MoA) and of its off-target effects. Previous approaches to elucidate drug MoA include analysis of chemical structures, transcriptional responses following treatment, and text mining. Methods based on transcriptional responses require the least amount of information and can be quickly applied to new compounds. Available methods are inefficient and are not able to support network pharmacology. We developed an automatic and robust approach that exploits similarity in gene expression profiles following drug treatment, across multiple cell lines and dosages, to predict similarities in drug effect and MoA. We constructed a “drug network” of 1,302 nodes (drugs) and 41,047 edges (indicating similarities between pair of drugs). We applied network theory, partitioning drugs into groups of densely interconnected nodes (i.e., communities). These communities are significantly enriched for compounds with similar MoA, or acting on the same pathway, and can be used to identify the compound-targeted biological pathways. New compounds can be integrated into the network to predict their therapeutic and off-target effects. Using this network, we correctly predicted the MoA for nine anticancer compounds, and we were able to discover an unreported effect for a well-known drug. We verified an unexpected similarity between cyclin-dependent kinase 2 inhibitors and Topoisomerase inhibitors. We discovered that Fasudil (a Rho-kinase inhibitor) might be “repositioned” as an enhancer of cellular autophagy, potentially applicable to several neurodegenerative disorders. Our approach was implemented in a tool (Mode of Action by NeTwoRk Analysis, MANTRA, http://mantra.tigem.it ).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GHK, as one of the compounds studied, increased mRNA production in 268 genes while suppressing 167 [17].”
From GHK-Cu may Prevent Oxidative Stress in Skin by Regulating Copper and Modifying Expression of Numerous Antioxidant Genes (2015) · cites this paper as [17]
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Modularity and community structure in networks
Newman, M. E. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601602103 · Cited by 12,256
Clustering by Passing Messages Between Data Points
Frey, B. J., & Dueck, D. (2007) · Science · doi:10.1126/science.1136800 · Cited by 6,758
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
Network pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622
Functional Discovery via a Compendium of Expression Profiles
Hughes, T. R., Marton, M. J., Jones, A. R., Roberts, C. J., Stoughton, R., Armour, C. D., Bennett, H. A., Coffey, E., Dai, H., He, Y. D., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00015-5 · Cited by 2,533
Autophagy Is Activated for Cell Survival after Endoplasmic ReticulumStress
Ogata, M., Hino, S.-I., Saito, A., Morikawa, K., Kondo, S., Kanemoto, S., Murakami, T., Taniguchi, M., Tanii, I., Yoshinaga, K., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01453-06 · Cited by 1,832
Predicting new molecular targets for known drugs
Keiser, M. J., Setola, V., Irwin, J. J., Laggner, C., Abbas, A. I., Hufeisen, S. J., Jensen, N. H., Kuijer, M. B., Matos, R. C., Tran, T. B., et al. (2009) · Nature · doi:10.1038/nature08506 · Cited by 1,667 · cited 1×
“Prediction of drug MoA has been attempted by using gene expression profiles following drug treatment (7 – 13), by comparing side-effect similarities (14), by text-mining literature (15), or by applying chemoinformatic tools to search for small molecules similarities (16, 17).”
Mammalian cyclin-dependent kinases
Malumbres, M., & Barbacid, M. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.09.005 · Cited by 1,295
Drug target identification using side-effect similarity
Campillos, M., Kuhn, M., Gavin, A.-C., Jensen, L. J., & Bork, P. (2008) · Science · doi:10.1126/science.1158140 · Cited by 1,248 · cited 1×
“Prediction of drug MoA has been attempted by using gene expression profiles following drug treatment (7 – 13), by comparing side-effect similarities (14), by text-mining literature (15), or by applying chemoinformatic tools to search for small molecules similarities (16, 17).”
Inferring Genetic Networks and Identifying Compound Mode of Action via Expression Profiling
Gardner, T. S., di Bernardo, D., Lorenz, D., & Collins, J. J. (2003) · Science · doi:10.1126/science.1081900 · Cited by 1,117
The Connectivity Map: A new tool for biomedical research
Lamb, J. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2044 · Cited by 945 · cited 3×
“Among the most promising approaches are the ones based on “ gene signatures ” (11, 12), i.e., subset of genes whose differential expression can be used as a marker of the activity of a given pathway, disease or compound.”
BackgroundMethodMethods for monitoring autophagy
Mizushima, N. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.02.005 · Cited by 881
Potential therapeutic applications of autophagy
Rubinsztein, D. C., Gestwicki, J. E., Murphy, L. O., & Klionsky, D. J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2272 · Cited by 862
Spearman's Footrule as a Measure of Disarray
Diaconis, P., & Graham, R. L. (1977) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1977.tb01624.x · Cited by 640
Kohanski, M. A., Dwyer, D. J., Wierzbowski, J., Cottarel, G., & Collins, J. J. (2008) · Cell · doi:10.1016/j.cell.2008.09.038 · Cited by 574
Network analyses in systems pharmacology
Berger, S. I., & Iyengar, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp465 · Cited by 510
Drug data coding and analysis in epidemiologic studies
Pahor, M., Chrischilles, E. A., Guralnik, J. M., Brown, S. L., Wallace, R. B., & Carbonin, P. (1994) · European Journal of Epidemiology · doi:10.1007/bf01719664 · Cited by 490
Eccles, S. A., Massey, A., Raynaud, F. I., Sharp, S. Y., Box, G., Valenti, M., Patterson, L., de Haven Brandon, A., Gowan, S., Boxall, F., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5256 · Cited by 479
Target deconvolution strategies in drug discovery
Terstappen, G. C., Schlüpen, C., Raggiaschi, R., & Gaviraghi, G. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2410 · Cited by 429
Hehner, S. P., Hofmann, T. G., Dröge, W., & Schmitz, M. L. (1999) · PubMed · Cited by 386
Hehner, S. P., Hofmann, T. G., Dröge, W., & Schmitz, M. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.10.5617 · Cited by 355
Chemogenomic profiling on a genome-wide scale using reverse-engineered gene networks
di Bernardo, D., Thompson, M. J., Gardner, T. S., Chobot, S. E., Eastwood, E. L., Wojtovich, A. P., Elliott, S. J., Schaus, S. E., & Collins, J. J. (2005) · Nature Biotechnology · doi:10.1038/nbt1075 · Cited by 344
Flavopiridol: the First Cyclin-Dependent Kinase Inhibitor in Human Clinical Trials
Senderowicz, A. M. (1999) · Investigational New Drugs · doi:10.1023/a:1006353008903 · Cited by 330
Human Disease-Drug Network Based on Genomic Expression Profiles
Hu, G., & Agarwal, P. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006536 · Cited by 310
Regulation of autophagy by the inositol trisphosphate receptor
Criollo, A., Maiuri, M. C., Tasdemir, E., Vitale, I., Fiebig, A. A., Andrews, D., Molgó, J., Díaz, J., Lavandero, S., Harper, F., et al. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402099 · Cited by 305
ChemBank: a small-molecule screening and cheminformatics resource database
Seiler, K. P., George, G. A., Happ, M. P., Bodycombe, N. E., Carrinski, H. A., Norton, S., Brudz, S., Sullivan, J. P., Muhlich, J., Serrano, M., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm843 · Cited by 280
Yang, H., Shi, G., & Dou, Q. P. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.030015 · Cited by 226
Mani, K. M., Lefebvre, C., Wang, K., Lim, W. K., Basso, K., Dalla‐Favera, R., & Califano, A. (2008) · Molecular Systems Biology · doi:10.1038/msb.2008.2 · Cited by 205
Finding multiple target optimal intervention in disease‐related molecular network
Yang, K., Bai, H., Ouyang, Q., Lai, L., & Tang, C. (2008) · Molecular Systems Biology · doi:10.1038/msb.2008.60 · Cited by 186
Li, J., Zhu, X., & Chen, J. Y. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000450 · Cited by 185
Rich-club phenomenon across complex network hierarchies
McAuley, J. J., da Fontoura Costa, L., & Caetano, T. S. (2007) · Applied Physics Letters · doi:10.1063/1.2773951 · Cited by 164
Brasca, M. G., Amboldi, N., Ballinari, D., Cameron, A., Casale, E., Cervi, G., Colombo, M., Colotta, F., Croci, V., D’Alessio, R., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9006559 · Cited by 127
Self-citationLei, X., Chen, Y., Du, G., Yu, W., Wang, X., Qu, H., Xia, B., He, H., Mao, J., Zong, W., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5665fje · Cited by 121
Ravikumar, B. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg109 · Cited by 110
Yang, Q., Huang, W., Jozwik, C., Lin, Y., Glasman, M., Caohuy, H., Srivastava, M., Esposito, D., Gillette, W., Hartley, J. L., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504097102 · Cited by 103
Identifying Network of Drug Mode of Action by Gene Expression Profiling
Iorio, F., Tagliaferri, R., & Bernardo, D. D. (2009) · Journal of Computational Biology · doi:10.1089/cmb.2008.10tt · Cited by 101
Self-citationChemical database techniques in drug discovery
Miller, M. A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd745 · Cited by 100
de Medina, P., Silvente-Poirot, S., & Poirot, M. (2009) · Autophagy · doi:10.4161/auto.5.7.9820 · Cited by 94
The value of proteasome inhibition in cancer
Cvek, B., & Dvořák, Z. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.05.003 · Cited by 86
DrugBank and its Relevance to Pharmacogenomics
Wishart, D. S. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.8.1155 · Cited by 78
Abal, M., Bras-Gonçalves, R., Judde, J., Fsihi, H., de Crémoux, P., Louvard, D., Magdelénat, H., Robine, S., & Poupon, M. (2004) · Oncogene · doi:10.1038/sj.onc.1207299 · Cited by 53
Computational Biology and Drug Discovery: From Single-Target to Network Drugs
Ambesi-Impiombato, A., & Bernardo, D. (2006) · Current Bioinformatics · doi:10.2174/157489306775330598 · Cited by 47
Liu, W., & Zhang, R. (1998) · International Journal of Oncology · doi:10.3892/ijo.12.4.793 · Cited by 47
Space Oriented Rank-Based Data Integration
Lin, S. (2010) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1534 · Cited by 44
Camptothecin releases P-TEFb from the inactive 7SK snRNP complex
Amente, S., Gargano, B., Napolitano, G., Lania, L., & Majello, B. (2009) · Cell Cycle · doi:10.4161/cc.8.8.8286 · Cited by 30
Research works printed but not linked: 1
- U Schwabe ATC-Code (Wissenschaftliches Institut der AOK, Bonn, Germany, 1995).
Cited by
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Autophagy · doi:10.1080/15548627.2015.1100356 · Cited by 5,894
Drug repurposing: progress, challenges and recommendations
Pushpakom, S., Iorio, F., Eyers, P. A., Escott, K. J., Hopper, S., Wells, A., Doig, A., Guilliams, T., Latimer, J., McNamee, C., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.168 · Cited by 4,718
Self-citationGuidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1
Klionsky, D. J., Abdel-Aziz, A. K., Abdelfatah, S., Abdellatif, M., Abdoli, A., Abel, S., Abeliovich, H., Abildgaard, M. H., Abudu, Y. P., Acevedo-Arozena, A., et al. (2021) · Autophagy · doi:10.1080/15548627.2020.1797280 · Cited by 2,897
Systematic identification of genomic markers of drug sensitivity in cancer cells
Garnett, M. J., Edelman, E. J., Heidorn, S. J., Greenman, C. D., Dastur, A., Lau, K. W., Greninger, P., Thompson, I. R., Luo, X., Soares, J., et al. (2012) · Nature · doi:10.1038/nature11005 · Cited by 2,456
Self-citationTarget identification and mechanism of action in chemical biology and drug discovery
Schenone, M., Dančík, V., Wagner, B. K., & Clemons, P. A. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1199 · Cited by 1,096
Metadata
- Authors
- Iorio, F., Bosotti, R., Scacheri, E., Belcastro, V., Mithbaokar, P., Ferriero, R., Murino, L., Tagliaferri, R., Brunetti-Pierri, N., Isacchi, A., & di Bernardo, D.
- Affiliations
- University of Salerno (IT)
- Nerviano Medical Sciences (IT)
- Telethon Institute Of Genetics And Medicine (IT)
- TeleThon Institute of Genetics and Medicine, Naples, Italy;
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2010-08-02
- Volume
- 107
- Issue
- 33
- Pages
- 14621-14626
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2930479
- OpenAlex
- W2094791588
- Cited by
- 816
- References
- 46
- Citations by year
- 2026: 18 · 2025: 33 · 2024: 26 · 2023: 53 · 2022: 42 · 2021: 51 · 2020: 53 · 2019: 72 · 2018: 64 · 2017: 52 · 2016: 77 · 2015: 72 · 2014: 54 · 2013: 57 · 2012: 58
- FWCI
- 48.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fondazione Telethon (TCBP37TELC)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Health Sciences › Medicine › Health Informatics › Biomedical Text Mining and Ontologies
- Keywords
- drug mode of action, drug repurposing, transcriptional response, gene expression profiles, drug networks, community detection, off-target effects, anticancer agents, topoisomerase inhibitors, fasudil, autophagy, neurodegenerative diseases, network pharmacology, mantras
- MeSH terms
- Irinotecan, Algorithms, Antineoplastic Agents, Autophagy, Camptothecin, Doxorubicin, Drug Screening Assays, Antitumor, Flavonoids, HeLa Cells, Humans, Neoplasms, Phosphorylation, Piperidines, Pyrazoles, Pyrroles, RNA Polymerase II, Blotting, Western, Gene Expression Regulation, Neoplastic, Fuzzy Logic, 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Cell Line, Tumor, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.